SAR302503

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for SAR302503, covering 2025-03-05 to 2026-08-11. Get the full timeline:

Most recent: Clinical Trial Results: Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis [Phase 3]